Crossmark Global Holdings Inc. Has $567,000 Holdings in LivaNova PLC (LIVN)

Crossmark Global Holdings Inc. boosted its holdings in LivaNova PLC (NASDAQ:LIVN) by 88.6% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 7,090 shares of the company’s stock after buying an additional 3,330 shares during the period. Crossmark Global Holdings Inc.’s holdings in LivaNova were worth $567,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Cerebellum GP LLC purchased a new stake in LivaNova in the 4th quarter worth $128,000. PNC Financial Services Group Inc. increased its stake in LivaNova by 9.8% in the 2nd quarter. PNC Financial Services Group Inc. now owns 1,707 shares of the company’s stock worth $105,000 after buying an additional 153 shares in the last quarter. Pillar Pacific Capital Management LLC purchased a new stake in LivaNova in the 4th quarter worth $208,000. Shelton Capital Management purchased a new stake in LivaNova in the 3rd quarter worth $209,000. Finally, Quantitative Systematic Strategies LLC purchased a new stake in LivaNova in the 3rd quarter worth $284,000. Institutional investors and hedge funds own 87.06% of the company’s stock.

LivaNova PLC (NASDAQ:LIVN) opened at $85.85 on Tuesday. The firm has a market capitalization of $4,138.96, a PE ratio of 73.38, a PEG ratio of 2.55 and a beta of 0.83. The company has a current ratio of 2.03, a quick ratio of 1.42 and a debt-to-equity ratio of 0.04. LivaNova PLC has a 12-month low of $46.34 and a 12-month high of $88.56.

In related news, Director Hugh M. Morrison sold 1,830 shares of the stock in a transaction dated Wednesday, November 29th. The shares were sold at an average price of $88.00, for a total value of $161,040.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Alfred J. Novak sold 2,000 shares of the stock in a transaction dated Wednesday, November 22nd. The shares were sold at an average price of $85.77, for a total transaction of $171,540.00. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 6,830 shares of company stock valued at $578,850. Company insiders own 0.28% of the company’s stock.

A number of research analysts have recently weighed in on LIVN shares. ValuEngine upgraded LivaNova from a “hold” rating to a “buy” rating in a research report on Thursday, November 2nd. BidaskClub lowered LivaNova from a “buy” rating to a “hold” rating in a research report on Wednesday, February 14th. Canaccord Genuity restated a “hold” rating and set a $76.00 price objective on shares of LivaNova in a research report on Tuesday, December 5th. Piper Jaffray Companies restated a “buy” rating and set a $85.00 price objective on shares of LivaNova in a research report on Friday, November 3rd. Finally, Needham & Company LLC raised their price objective on LivaNova from $93.00 to $97.00 and gave the company a “buy” rating in a research report on Tuesday, December 5th. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating and five have assigned a buy rating to the stock. LivaNova currently has an average rating of “Hold” and an average price target of $79.71.

WARNING: This news story was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this news story on another site, it was illegally copied and reposted in violation of US and international trademark & copyright laws. The correct version of this news story can be viewed at https://www.dispatchtribunal.com/2018/02/20/crossmark-global-holdings-inc-has-567000-holdings-in-livanova-plc-livn.html.

About LivaNova

LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.

Want to see what other hedge funds are holding LIVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LivaNova PLC (NASDAQ:LIVN).

Institutional Ownership by Quarter for LivaNova (NASDAQ:LIVN)

Receive News & Ratings for LivaNova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply